Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction
dc.contributor.author | Sheppard, M | en_US |
dc.contributor.author | Spencer, RN | en_US |
dc.contributor.author | Ashcroft, R | en_US |
dc.contributor.author | David, AL | en_US |
dc.contributor.author | Consortium, EVERREST | en_US |
dc.date.accessioned | 2016-06-08T12:28:07Z | |
dc.date.available | 2016-01-29 | en_US |
dc.date.issued | 2016-04 | en_US |
dc.date.submitted | 2016-04-06T12:43:27.405Z | |
dc.identifier.issn | 0960-7692 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12736 | |
dc.format.extent | 484 - 491 | en_US |
dc.relation.ispartof | ULTRASOUND IN OBSTETRICS & GYNECOLOGY | en_US |
dc.rights | “The final publication is available at http://onlinelibrary.wiley.com/doi/10.1002/uog.15880/full” | |
dc.subject | ethics | en_US |
dc.subject | fetal growth restriction | en_US |
dc.subject | gene therapy | en_US |
dc.subject | pregnancy | en_US |
dc.subject | qualitative | en_US |
dc.subject | translational medicine | en_US |
dc.title | Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1002/uog.15880 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373915900014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 47 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Department of Law [862]